Angiotensin II Receptor Blocker Telmisartan Prevents New-Onset Diabetes in Pre-Diabetes OLETF Rats on a High-Fat Diet: Evidence of Anti-Diabetes Action-Reference-Cited by-同舟云学术

Angiotensin II Receptor Blocker Telmisartan Prevents New-Onset Diabetes in Pre-Diabetes OLETF Rats on a High-Fat Diet: Evidence of Anti-Diabetes Action

Published:2013-06 Issue:3 Volume:37 Page:156-168
ISSN:1499-2671
Container-title:Canadian Journal of Diabetes
language:en
Short-container-title:Canadian Journal of Diabetes

Author:

Zhao Zi-Qin,Luo Rong,Li Lan-Ying,Tian Feng-Shi,Zheng Xi-Lan,Xiong Hai-Liang,Sun Li-Ting

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference37 articles.

1. Renal and vascular protective effects of telmisartan in patients with essential hypertension;Morimoto;Hypertens Res,2006

2. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial;Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators;Lancet,2008

3. Effects of telmisartan on glucose levels in people at high risk for cardiovascular disease but free from diabetes: the TRANSCEND study;Barzilay;Diabetes Care,2011

4. Angiotensin receptor blockers for prevention of new-onset type 2 diabetes: a meta-analysis of 59,862 patients;Geng;Int J Cardiol,2012

5. Effect of ramipril on the incidence of diabetes;DREAM Trial Investigators;N Engl J Med,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of telmisartan on metabolic syndrome components: a comprehensive review;Biomedicine & Pharmacotherapy;2024-02

2. Telmisartan versus metformin in downregulating myostatin gene expression and enhancing insulin sensitivity in the skeletal muscles of type 2 diabetic rat model;Frontiers in Pharmacology;2023-07-28

3. An insight into the role of telmisartan as PPAR‐γ/α dual activator in the management of nonalcoholic fatty liver disease;Biotechnology and Applied Biochemistry;2021-03

4. PPAR Modulation Through Posttranslational Modification Control;Nuclear Receptors;2021

5. Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways;International Immunopharmacology;2020-05